1.Nordmann, P, Naas, T, Poirel, L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791–1798.
2.Spellberg, B, Guidos, R, Gilbert, D, et al. The epidemie of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155–164.
3.Chen, IL, Lee, CH, Su, LH, Tang, YF, Chang, SJ, Liu, JW. Antibiotic consumption and healthcare-associated infections caused by mul-tidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship. PLoS One 2013;8(5):e65621.
4.Antoine, TL, Curtis, AB, Blumberg, HM, et al. Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study. Infect Cont Hosp Epidemiol 2006;27:1274–1277.
5.Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Cont Hosp Epidem 2009;30:931–938.
6.McConnell, SA, Penzak, SR, Warmack, TS, Anaissie, EJ, Gubbins, PO. Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy. Clin Infect Dis 2000;31:1512–1514.
7.Prescott, WA, DePestel, DD, Ellis, JJ, Regal, RE. Incidence of car-bapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infec Dis 2004;38:1102–1107.
8.Romano, A, Viola, M, Gueant-Rodriguez, RM, Gaeta, F, Pettinato, R, Gueant, JL. Imipenem in patients with immediate hypersensitivity to penicillins. New Engl J Med 2006;354:2835–2837.
9.van Belkum, A, Durand, G, Peyret, M, et al. Rapid clinical bacteriology and its future impact. Ann Lab Med 2013;33:14–27.